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Case Report
Nitrobenzene poisoning with methemoglobinemia
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Nitrobenzene poisoning is rare in clinical practice. Nitrobenzene is a pale yellow-colored liquid with bitter almond odor. It is commonly used in the manufacture 
of aniline, benzidine, quinolone, drugs, dyes, solvent in shoe, 
metal polishes, and in screen printing [1]. Rarely, it is used as 
a flowering stimulant by gardeners as in our case. The most 
common manifestation of poisoning with nitrobenzene is 
methemoglobinemia and its early intervention can be life-saving. 
We report a case of nitrobenzene poisoning in a 35-year-old male 
which was later on successfully treated.
CASE REPORT
A 35-year-old male presented to the emergency department 
with an alleged history of ingestion of 22% nitrobenzene 
(Trade name - PROFIT) of around 100 ml. On examination, 
the Glasgow Coma Scale was E1V2M5 with cyanosis and a 
grayish-brown discoloration of palms and soles (Fig. 1). He had 
labored respiration with the rate of 36/min, blood pressure (BP) 
of 80/50 mm of Hg, and pulse rate of 140 beats/min. The patient 
had pupils with sluggish reaction and SpO2 of 60% on room air. 
His chest was clear. Rapid sequence intubation done; however, 
SpO2 remained at 81%.
Blood samples drawn for arterial blood gas (ABG) analysis 
had a chocolate brown color with a pH of 6.967, PaO2 111 mm of 
mercury, PaCO2 24.8 mm of mercury, HCO3 9.8 mEq/L, and SO2 
was undetectable. Based on the above-mentioned investigations, 
a provisional diagnosis of severe metabolic acidosis was made. 
An X-ray of the chest was normal and electrocardiogram showed 
tachycardia. Blood investigations revealed elevated total count 
and deranged renal parameters. Liver enzymes were elevated: 
Aspartate transaminase was 144 U/L and alanine transaminase 
was 139 U/L. A clinical and final diagnosis of methemoglobinemia 
was made keeping in mind the clinical, radiographic, and blood 
investigations.
He was started on vasopressors to improve the BP. Intravenous 
methylene blue (prepared as 1% sterile solution) 1 mg/kg was 
given to the patient. The ABG was repeated after 6 h with pH of 
7.441, PaO2 79.4 mm of mercury, PaCO2 28.1 mm of mercury, 
HCO3 18mEq/L, and SO2 91.4%. BP and sensorium improved over 
the next 24 h; however, the patient had dark green discoloration 
of urine (Fig. 2). Methemoglobin level was 14.9% (normal value 
up to 1% in adults).
The patient was weaned off the ventilator on day 3. His 
SpO2 continued to be around 85–87% for the next 3 days even 
on 100% oxygen. On day 6, there was a drop in hemoglobin 
to 5.1 gm/dL. Lactate dehydrogenase was 750 units, total 
bilirubin was 2.5 units/L, and direct bilirubin was 1.3 units/L. 
Peripheral smear showed microcytic hypochromic anemia, 
anisopoikilocytosis with schistocytes, microcytes, and target 
cells suggestive of hemolysis (Fig. 3). Repeat methemoglobin 
was 6.25%. The patient required packed red cell transfusions. 
The patient also had ventilator-associated pneumonia which was 
managed successfully with antibiotics and he was discharged on 
day 14. A follow-up was planned after 1 month, but unfortunately, 
the patient was lost to follow-up.
DISCUSSION
Methemoglobinemia commonly caused by ingestion or skin 
exposure to an oxidizing agent. Aniline, benzocaine, dapsone, 
phenazopyridine (Pyridium), nitrites, nitrates, copper sulfate, and 
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naphthalene are the commonly encountered drugs and toxins with 
methemoglobinemia. Chlorates (sodium, potassium, or barium) 
are used in the manufacture of explosives, matches, dyes, weed 
killers and as a mouthwash, and weak antiseptic [2].
The rapid development of methemoglobinemia is responsible 
for the toxic effect of nitrobenzene [3]. The iron within the 
hemoglobin is oxidized from the ferrous (Fe2+) state to the ferric 
(Fe3+) state, resulting in the inability to transport oxygen and causes 
a brownish discoloration of the blood [4]. Methemoglobin once 
formed reduced enzymatically either through an Nicotinamide 
Adenine Dinucleotide (NADH)-dependent reaction, catalyzed 
by cytochrome b5 reductase, or an alternative pathway utilizing 
the Nicotinamide Adenine Dinucleotide Phosphate (NADPH)-
dependent methemoglobin reductase system.
During acute intoxication, patients are asymptomatic showing 
the only cyanosis up to the level of 10–15% of methemoglobin. 
A headache, dyspnea, chest pain, tachypnea, and tachycardia 
develop when methemoglobin is >20%. At 40–50%, confusion, 
lethargy, and metabolic acidosis occur, leading to coma, seizures, 
bradycardia, ventricular dysrhythmia, and hypertension. Fractions 
around 70% are fatal. Anemic or G6PD-deficient patients suffer 
more severe symptoms [5].
Methylene blue is an exogenous cofactor, which accelerates 
the NADPH-dependent methemoglobin reductase system and 
is indicated if the methemoglobin levels, which are >30%, and 
hence, it is an effective antidote for methemoglobinemia [3]. It 
is administered intravenously at 1–2 mg/kg (up to 50 mg dose 
in adults) as a 1% solution over 5 min, with a repeat in 1 h, if 
necessary. Methylene blue is an oxidant at levels of >7 mg/kg 
and, therefore, may cause methemoglobinemia in susceptible 
patients [4]. Oral methylene blue (2 mg/kg) also can be used as 
an alternative to intravenous preparation [1]. It is contraindicated 
in patients with G6PD deficiency because it can lead to severe 
hemolysis. Ascorbic acid is an antioxidant also useful in some 
cases [4]. Exchange transfusion is indicated in severe cases [3]. 
Hyperbaric oxygen is reserved only for those patients who have 
a methemoglobin level >50% or those who do not respond to 
standard treatment [5]. N-acetyl cysteine has also been tried 
among some patients [4].
Hemolytic anemia has been described in a limited number 
of studies before, however, dropping hemoglobin and peripheral 
smear suggestive of hemolysis as in our patient suggestive of 
oxidative damage to the red blood cells [6].
CONCLUSION
Early diagnosis of methemoglobinemia with nitrobenzene 
poisoning and early initiation of treatment with methylene blue 
can result in the good outcome as in our patient. Nitrobenzene 
poisoning is uncommon also methylene blue intravenous 
preparations are not readily available. Methemoglobin estimation 
also takes time in semi-urban settings where clinical judgment 
has a more superior role in early detection and treatment.
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Figure 1: Cyanosis and a grayish-brown discoloration of palms, 
Figure 2: Dark green discoloration of urine, Figure 3: Peripheral 
smear showed microcytic hypochromic anemia, anisopoikilocytosis 
with schistocytes, microcytes, and target cells suggestive of hemolysis
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